ProShare Advisors’s Lifecore Biomedical LFCR Stock Holding History

ProShare Advisors’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-10,522	Closed	-$129K	–	2050
2014 Q3	$129K	Sell	10,522 -2,371	-18%	-$29.6K	﹤0.01%	2123
2014 Q2	$161K	Sell	12,893 -13,356	-51%	-$157K	﹤0.01%	2251
2014 Q1	$293K	Buy	+26,249	New	+$288K	﹤0.01%	2255
2013 Q4	–	Sell	-16,380	Closed	-$200K	–	1617
2013 Q3	$200K	Sell	16,380 -143	-0.9%	-$2K	﹤0.01%	2197
2013 Q2	$218K	Buy	+16,523	New	+$228K	﹤0.01%	1964

Other funds holding LFCR

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

ProShare Advisors's LFCR Position: Q4 2014 in Review

ProShare Advisors sold out of Lifecore Biomedical (LFCR) in Q4 2014, closing a stake of 10,522 shares — an estimated $129K sold.

ProShare Advisors first reported a position in LFCR in Q2 2013 and held it in 5 quarters. The position peaked at $293K in Q1 2014. 109 funds tracked by Wall St. Rank hold LFCR as of Q4 2014.

ProShare Advisors reported no remaining Lifecore Biomedical position as of Q4 2014 after selling out during the quarter.
ProShare Advisors sold 10,522 Lifecore Biomedical shares in Q4 2014, an estimated $129K.
ProShare Advisors first reported a position in Lifecore Biomedical in Q2 2013 and held it in 5 quarters.
ProShare Advisors's Lifecore Biomedical position peaked at $293K in Q1 2014.
109 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2014.

Based on ProShare Advisors's 13F filing for Q4 2014, filed 30 Jan 2015.